The blend is studied in preclinical and in vitro models in relation to gastrointestinal stability, mucosal transport and biodistribution of encapsulated peptides. Research also examines BPC-157-associated cytoprotective signaling, TB-500-associated cell migration and cytoskeletal regulation, and how co-formulation affects peptide integrity.